Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03548701 · ClinicalTrials.gov registry record
Thromboelastometry Prediction Utility for Risk of Abortion
A clinical trial of Pregnancy Trimester, First and Abortion, Threatened, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 98
- Enrollment target
- 1
- Study location
NCT03548701 is a study of Pregnancy Trimester, First and Abortion, Threatened that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 98 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03548701, a study of Pregnancy Trimester, First and Abortion, Threatened, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will use thromboelastometry in ED patients with vaginal bleeding, as well as healthy pregnant controls, to determine if abnormal results are associated with the presence of vaginal bleeding as well as later complications during pregnancy.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Thromboelastometry testing
Study Locations (1)
New York
- Mount Sinai Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2018-06-04 |
| Est. Completion | 2019-05-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03548701
The ClinicalTrials.gov registry entry for NCT03548701 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pregnancy Trimester, First appearing as the primary indexed condition, and to 1 intervention - of which Thromboelastometry testing is the first listed.
NCT03548701 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03548701 about?
NCT03548701 is a clinical study titled "Thromboelastometry Prediction Utility for Risk of Abortion". This study will use thromboelastometry in ED patients with vaginal bleeding, as well as healthy pregnant controls, to determine if abnormal results are associated with the presence of vaginal bleeding as well as later complications during pregnancy.
What is the current status of trial NCT03548701?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2018-06-04. Estimated completion is 2019-05-15.
What conditions does trial NCT03548701 study?
This clinical trial studies the following conditions: Pregnancy Trimester, First, Abortion, Threatened.
What interventions are being tested in trial NCT03548701?
The interventions under investigation include: Thromboelastometry testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03548701?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03548701 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.